A subsidiary of multibillion-dollar international pharmaceuticals company Allergan has agreed to plead guilty to a felony charge of healthcare fraud and pay $125 million to close the books on criminal and civil liability claims tied to the subsidiary’s illegal marketing activities for seven different name-brand prescription drugs. [More]
There are numerous ways for makers of pricey brand-name drugs to delay the release of generic copies and hold on to the market for even a few months longer. They could make slight changes to the doses or even go so far as to buy a company that supplies a needed ingredient. But one pharmaceutical company is taking a new approach to putting off the release of generic versions — etching an additional score into the pill’s surface.
Reddit user TheKarateKid says he emailed a major drug company asking why their $500 version of a $10 generic is worth the $490 markup. The drug company rep accidentally emailed the customer back this message intended for her colleague.